Abstract
Telomerase is now a significant factor in the fight against cancer and antiaging (1). It is becoming a valuable prognostic tool to determine if a particular tissue is likely to develop cancer (2). The ability to detect telomerase activity in patients with cancer has also been correlated with clinical staging of some tumors (3-7). The regulation of telomerase and the ability to inhibit the enzyme is also an important aspect in future drug development for both anticancer and antiaging purposes (8-11). Thus, the most sensitive and accurate methods are needed to detect telomerase in various sample formats.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fossel, M. (1998) Telomerase and the aging cell: implications for human health. JAMA 279, 1732–1735.
Shay, J. W., Werbin, H., and Wright, W. E. (1997) Telomerase assays in the diagnosis and prognosis of cancer. CIBA Found. Symp. 211, 148–155.
Brinkschmidt, C., Poremba, C., Christiansen, H., et al. (1998) Comparative genomic hybridization and telomerase activity analysis identify two biologicall different groups of 4s neuroblastomas. Br. J. Cancer 77, 2223–2229.
Brown T., Aldous, W., Lance, R., Blaser, J., Baker, T., and Williard, W. (1998) The association between telomerase, p53, and clinical staging on colorectal cancer. Am. J. Surg. 175, 364–366.
Oishi, T., Kigawa, J., Minagawa, Y., Shimada, M., Takahashi, M., and Terakawa N. (1998) Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet. Gynecol. 91, 568–571.
Albanell, J., Lonardo, F., Rusch, V., et al. (1997) High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. 89, 1609–1615.
Kannan, S., Tahara, H., Yokozaki, H., et al. (1997) Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol. Biomarkers Prev. 6, 413–420.
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., and Corey, D.R. (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol. 14, 615–619.
Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Barna, B. P., and Cowell, J. K. (1998) Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16, 2243–2248.
Nugent, C. I. and Lundblad, V. (1998) The telomerase revers transcriptase: components and regulation. Genes Dev. 12, 1073–1085.
Kosciolek, B. A. and Rowley, P. T. (1998) Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer 21, 124–130.
Greider, C. W. and Blackburn E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405–413.
Kim, N. W., Piatyszek, M. A., Prowse, K. R., et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015.
Aldous, W. K. and Grabill, N. R. (1997) A fluorescent method for detection of telomerase activity. Diagn. Mol. Pathol. 6, 102–110.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Aldous, W.K., Marean, A.J., DeHart, M.J., Moore, K.H. (2002). Fluorescent Detection of Telomerase Activity. In: Double, J.A., Thompson, M.J. (eds) Telomeres and Telomerase. Methods in Molecular Biology™, vol 191. Humana Press. https://doi.org/10.1385/1-59259-189-2:137
Download citation
DOI: https://doi.org/10.1385/1-59259-189-2:137
Publisher Name: Humana Press
Print ISBN: 978-0-89603-657-4
Online ISBN: 978-1-59259-189-3
eBook Packages: Springer Protocols